In brief
In a landmark appeals decision, a Korean court overturned a murder conviction against a woman who had sought a 36‑week abortion that led to the killing of her newborn. The case underscores the regulatory gaps surrounding late‑stage abortions in South Korea. Although doctors involved in the procedure received reduced sentences, the woman’s acquittal highlights doubts about her knowledge of the baby’s fate. Advocates call for clearer legal safeguards to protect pregnant individuals. The ruling highlights ongoing tensions around reproductive rights and the need for policy reform.
A Seoul‑based appeals court has cleared a woman previously convicted of murder after a 36‑week abortion that concluded with the death of a live newborn, a verdict that has ignited fresh debate over Korea’s abortion policy.
The woman, whose name is not publicly disclosed, aired a YouTube vlog detailing her desire to end a pregnancy at about eight months and the distress it caused public attention. Prosecutors argued that the baby survived a Caesarean section and was killed thereafter, leading to the original murder sentencing.
The appellate panel, however, granted her acquittal by concluding she had no knowledge that the baby would be killed after being removed from her womb. It noted that a broker had misled her, portraying the infant as stillborn.
In contrast, three doctors involved received attenuated sentences—one’s term dropped from four years to two and a half, and another’s from six to four years. All admitted to ending the baby's life in court.
Activists from Amnesty International Korea praised the decision yet stressed that the absence of clear abortion regulations leaves pregnant people exposed to unsafe procedures. They call on lawmakers to lift barriers and enforce protective legislation.
This case spotlights the vacuum in South Korea’s late‑stage abortion law following the Constitutional Court’s 2019 decision to remove a longstanding ban. The court suggested an amendment to restrict abortions to 22 weeks, but parliamentary debate stalled substantial legislative steps.
Conclusively, the ruling echoes the pressing need for comprehensive, clear rules governing late‑stage reproductive choices while ensuring medical accountability and safeguarding patient informed consent.
